These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 34639229)

  • 21. Event-related Potentials Improve the Efficiency of Cerebrospinal Fluid Biomarkers for Differential Diagnosis of Alzheimer's Disease.
    Babić Leko M; Krbot Skorić M; Klepac N; Borovečki F; Langer Horvat L; Vogrinc Ž; Sonicki Z; Hof PR; Šimić G
    Curr Alzheimer Res; 2018; 15(13):1244-1260. PubMed ID: 30207231
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CSF tau and the CSF tau/ABeta ratio for the diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI).
    Ritchie C; Smailagic N; Noel-Storr AH; Ukoumunne O; Ladds EC; Martin S
    Cochrane Database Syst Rev; 2017 Mar; 3(3):CD010803. PubMed ID: 28328043
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CSF levels of the neuronal injury biomarker visinin-like protein-1 in Alzheimer's disease and dementia with Lewy bodies.
    Luo X; Hou L; Shi H; Zhong X; Zhang Y; Zheng D; Tan Y; Hu G; Mu N; Chan J; Chen X; Fang Y; Wu F; He H; Ning Y
    J Neurochem; 2013 Dec; 127(5):681-90. PubMed ID: 23800322
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Biological markers in Alzheimer's disease.
    Bailey P
    Can J Neurol Sci; 2007 Mar; 34 Suppl 1():S72-6. PubMed ID: 17469687
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical and biomarker profiling of prodromal Alzheimer's disease in workpackage 5 of the Innovative Medicines Initiative PharmaCog project: a 'European ADNI study'.
    Galluzzi S; Marizzoni M; Babiloni C; Albani D; Antelmi L; Bagnoli C; Bartres-Faz D; Cordone S; Didic M; Farotti L; Fiedler U; Forloni G; Girtler N; Hensch T; Jovicich J; Leeuwis A; Marra C; Molinuevo JL; Nobili F; Pariente J; Parnetti L; Payoux P; Del Percio C; Ranjeva JP; Rolandi E; Rossini PM; Schönknecht P; Soricelli A; Tsolaki M; Visser PJ; Wiltfang J; Richardson JC; Bordet R; Blin O; Frisoni GB;
    J Intern Med; 2016 Jun; 279(6):576-91. PubMed ID: 26940242
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Plasma and cerebrospinal fluid amyloid beta for the diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI).
    Ritchie C; Smailagic N; Noel-Storr AH; Takwoingi Y; Flicker L; Mason SE; McShane R
    Cochrane Database Syst Rev; 2014 Jun; 2014(6):CD008782. PubMed ID: 24913723
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Usefulness of EEG Techniques in Distinguishing Frontotemporal Dementia from Alzheimer's Disease and Other Dementias.
    Nardone R; Sebastianelli L; Versace V; Saltuari L; Lochner P; Frey V; Golaszewski S; Brigo F; Trinka E; Höller Y
    Dis Markers; 2018; 2018():6581490. PubMed ID: 30254710
    [TBL] [Abstract][Full Text] [Related]  

  • 28. M/EEG-Based Bio-Markers to Predict the MCI and Alzheimer's Disease: A Review From the ML Perspective.
    Yang S; Bornot JMS; Wong-Lin K; Prasad G
    IEEE Trans Biomed Eng; 2019 Oct; 66(10):2924-2935. PubMed ID: 30762522
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Saliva, an easily accessible fluid as diagnostic tool and potent stem cell source for Alzheimer's Disease: Present and future applications.
    Reale M; Gonzales-Portillo I; Borlongan CV
    Brain Res; 2020 Jan; 1727():146535. PubMed ID: 31669827
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fluid biomarkers in Alzheimer's disease - current concepts.
    Rosén C; Hansson O; Blennow K; Zetterberg H
    Mol Neurodegener; 2013 Jun; 8():20. PubMed ID: 23800368
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The clinical promise of biomarkers of synapse damage or loss in Alzheimer's disease.
    Colom-Cadena M; Spires-Jones T; Zetterberg H; Blennow K; Caggiano A; DeKosky ST; Fillit H; Harrison JE; Schneider LS; Scheltens P; de Haan W; Grundman M; van Dyck CH; Izzo NJ; Catalano SM;
    Alzheimers Res Ther; 2020 Mar; 12(1):21. PubMed ID: 32122400
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Electroencephalography-driven approach to prodromal Alzheimer's disease diagnosis: from biomarker integration to network-level comprehension.
    Moretti DV
    Clin Interv Aging; 2016; 11():897-912. PubMed ID: 27462146
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Alzheimer's disease biomarkers: their value in diagnosis and clinical trials.
    Small DH
    Front Biosci; 2002 Apr; 7():d986-8. PubMed ID: 11897567
    [TBL] [Abstract][Full Text] [Related]  

  • 34. EEG evidence of compensatory mechanisms in preclinical Alzheimer's disease.
    Gaubert S; Raimondo F; Houot M; Corsi MC; Naccache L; Diego Sitt J; Hermann B; Oudiette D; Gagliardi G; Habert MO; Dubois B; De Vico Fallani F; Bakardjian H; Epelbaum S;
    Brain; 2019 Jul; 142(7):2096-2112. PubMed ID: 31211359
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Critical Comparison of Different Biomarkers for Alzheimer's Disease in a Clinical Setting.
    Weise D; Tiepolt S; Awissus C; Hoffmann KT; Lobsien D; Kaiser T; Barthel H; Sabri O; Gertz HJ
    J Alzheimers Dis; 2015; 48(2):425-32. PubMed ID: 26402006
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Using static and dynamic canonical correlation coefficients as quantitative EEG markers for Alzheimer's disease severity.
    Waser M; Garn H; Deistler M; Benke T; Dal-Bianco P; Ransmayr G; Schmidt H; Sanin G; Santer P; Caravias G; Seiler S; Grossegger D; Fruehwirt W; Schmidt R
    Annu Int Conf IEEE Eng Med Biol Soc; 2014; 2014():2801-4. PubMed ID: 25570573
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fluid biomarker-based molecular phenotyping of Alzheimer's disease patients in research and clinical settings.
    Blennow K; Zetterberg H
    Prog Mol Biol Transl Sci; 2019; 168():3-23. PubMed ID: 31699324
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Progress update: fluid and imaging biomarkers in Alzheimer's disease.
    Sutphen CL; Fagan AM; Holtzman DM
    Biol Psychiatry; 2014 Apr; 75(7):520-6. PubMed ID: 24012326
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Charting the Next Road Map for CSF Biomarkers in Alzheimer's Disease and Related Dementias.
    Hu WT; Nayyar A; Kaluzova M
    Neurotherapeutics; 2023 Jul; 20(4):955-974. PubMed ID: 37378862
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Transitioning from cerebrospinal fluid to blood tests to facilitate diagnosis and disease monitoring in Alzheimer's disease.
    Alawode DOT; Heslegrave AJ; Ashton NJ; Karikari TK; Simrén J; Montoliu-Gaya L; Pannee J; O Connor A; Weston PSJ; Lantero-Rodriguez J; Keshavan A; Snellman A; Gobom J; Paterson RW; Schott JM; Blennow K; Fox NC; Zetterberg H
    J Intern Med; 2021 Sep; 290(3):583-601. PubMed ID: 34021943
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.